Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1057

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 85509-1057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (10574)

Ondansetron Tablets USP 4 mg film-coated tablets pack contains 12 tablets. Label shows NDC 85509-1057-4, manufactured by Aurobindo Pharma Limited and repackaged by PHOENIX RX LLC, Hatboro, PA. Storage instructions include protection from light and controlled room temperature. Packaging includes QR codes and barcodes.*

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical structure of Ondansetron Hydrochloride dihydrate showing its molecular framework including aromatic rings, nitrogen atoms, and associated hydrate and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.